期刊文献+

血清Hcy、CysC、尿β2–MG联合检测对早期糖尿病肾病的诊断价值 被引量:20

Clinical significance of detection of serum homocysteine,cystatin C and urine β2-microglobulin in diagnosis of early diagnosis of diabetic nephropathy
原文传递
导出
摘要 目的探讨血清同型半胱氨酸(Hcy)、血清胱抑素C(CysC)和尿β2-微球蛋白(β2-MG)联合检测对2型糖尿病早期肾病诊断的临床价值。方法检测119例2型糖尿病患者按尿液清蛋白排泄率分为A、B、C组:正常清蛋白组(A组,n=48),微量清蛋白组(B组,n=37),大量清蛋白组(C组,n=34),同时采用50例健康人作为健康对照组。分别检测Hcy、CysC、尿β2-MG水平,对检测结果进行统计学分析。结果糖尿病患者各组间血清Hcy、CysC、尿β2-MG水平检测结果比较差异均有统计学意义(P<0.05)。结论血清Hcy、CysC、尿β2-MG联合检测可以推断糖尿病肾病的损害程度,提示临床应早期干预血清同型半胱氨酸水平,几项指标联合检测在糖尿病肾病早期诊断中有较高的临床应用价值。 Objective To explore application of serum homocysteine,cystatin C and urine β2- microglobulin joint detection in diagnosis of diabetic nephropathy.Methods The 119 cases with diabetic nephropathy according to urinary albumin excretion rates:were divided into Group A(48 cases) with normal albumin,Group B(37 cases) with albumin,Group C(34 cases)with large amounts of albumin.At the same time,50 healthy subjects were enrolled as normal control group.Serum homocysteine,serum cystatin C,urine β2-microglobulin levels were detected and analyzed by using SPSS software.Results Serum homocysteine,serum cystatin C,urine β2- microglobulin between diabetic nephropathy groups were statistically different(P0.05).Conclusions The detection of serum homocysteine,serum cystatin C and urine β2-microglobulin can evaluate renal damage in diabetes patients,for early clinical intervention of serum homocysteine levels.Joint detection of Hcy、CysC and urine β2-MG is a sensitive and reliable for method for early diagnosis of diabetic nephropathy.
出处 《中国热带医学》 CAS 2014年第5期581-583,共3页 China Tropical Medicine
关键词 糖尿病肾病 同型半胱氨酸 血清胱抑素C Β2-微球蛋白 Diabetic nepnropathy Homocysteine Cystatin C β2-microglobulin
  • 相关文献

参考文献9

二级参考文献29

共引文献319

同被引文献159

  • 1王诚,何伶俐,胡新梅,王世君,余红岚.血清同型半胱氨酸和血清胱抑素C及尿β_2-微球蛋白联合检测对糖尿病肾病的临床价值[J].中国老年学杂志,2014,34(6):1509-1510. 被引量:14
  • 2李吉河,吴曼,娄岩,刘树军,苗里宁.生化检查及尿蛋白五项检查在诊断老年早期糖尿病肾病中的意义[J].中国老年学杂志,2014,34(7):1766-1767. 被引量:14
  • 3Cohen-Bucay A, Viswanathan G. Urinary markers of glomeru- lar injury in diabetic nephropathy[J]. Int J Nephrol, 2012, 2012:146987.
  • 4KIDQI. KDOQI Clinical Practice Guidelines and Clinical Prac- tice Recommendations for Diabetes and Chronic Kidney Disease [ J]. Am J Kidney Dis, 2007,49 (2 Suppl 2) : S12- S154.
  • 5Zoccali C ,Jager KJ. Hyperhomocysteinemia: a renal and cardi- ovascular risk factor? [J]. Nat Rev Nephrol, 2010, 6 (12) : 695-696.
  • 6Lan TH, Xu ZW, Wang Z, et al. Ginsenoside Rbl prevents homocysteine-induced endothelial dysfunction via PI3K/Aktac- tivation and PKC inhibition[J]. Biochem Pharmacol, 2011,82 (2) : 148-155.
  • 7Clio EH,Kim EH,Kim WG,et al. Homocysteine as a risk fac-tor for development of microalbuminuria in type 2 diabetes[J]. Korean Diabetes J, 2010,34 (3) : 200-206.
  • 8Wang H, Cui K, Xu K, et al. Association between plasma bo- mocysteine and progression of early nephropathy in type 2 dia- betic patients[J]. Int J Clin Exp Med, 2015, 8 (7): 11174- 11180.
  • 9Mogensen CE. Mieroalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas[J]. Diabetologia, 1999,42 (3) : 263-285.
  • 10Whiting PF, Westwood ME, Rutjes AW, et al. Evaluation of QUADAS: a tool for the quality assessment of diagnostic accu- racy studies[J]. BMC Med Res Methodol, 2006,6 : 9.

引证文献20

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部